A genome-wide RNAi screen identifies novel targets of neratinib resistance leading to identification of potential drug resistant genetic markers
Year: 2012
Type: article
Source: Molecular BioSystems
DOI: 10.1039/c2mb05512k
Institution: Pfizer (United States)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1986733915